Search results
2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever
Motley Fool via Yahoo Finance· 2 weeks agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool has a disclosure policy. 2...
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
InvestorPlace· 13 hours agoIn the changing environment of 2024, astute investors have a plethora of options to strengthen their...
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 1 day agodividend yields. Image Source: Getty Images. Pfizer (NYSE: PFE) and Viking Therapeutics (NASDAQ: VKTX) perfectly embody this situation ...
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
Motley Fool via Yahoo Finance· 1 week agoImage source: Getty Images. Pfizer (NYSE: PFE), Ares Capital (NASDAQ: ARCC), and AT&T (NYSE: T) look...
The Smartest Dividend Stocks to Buy With $400 Right Now
Motley Fool via Yahoo Finance· 2 weeks agoHowever, I think the company's juicy distribution yield of over 7% justifies the extra effort with...
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days agoIts recent price-to-sales ratio, for example, was 2.5, well below the five-year average of 3.4. On...
Zoetis Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 1 week agoZoetis Inc (NYSE:ZTS) recently announced a dividend of $0.43 per share, payable on 2024-06-04, with the ex-dividend date set for 2024-04-18. As investors...
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
Forbes· 6 days agoYou might think that a big, well-known healthcare firm offering a 6.6% dividend would attract investors. The drug maker is a big one with a market capitalization of $143 billion ...
Is Pfizer Stock a Buy?
Motley Fool via Yahoo Finance· 1 week agoRight now, Pfizer's dividend yield is high, at 6.3%. While there is a possibility that the yield could rise even further ...
Pfizer: The Market Is Wrong (NYSE:PFE)
Seeking Alpha· 2 weeks agoPfizer's stock sees drastic sell-off on COVID-related revenue decline, but recent moderation suggests undervaluation and attractive dividend< ...
